Skip to main content

65th ASH Annual Meeting and Exposition, December 9-12, 2023 in San Diego, California.Researchers from UNC Lineberger Comprehensive Cancer Center and UNC are in San Diego Dec. 8-12 presenting findings from studies, speaking at scientific symposia and leading educational sessions at the 65th American Society of Hematology (ASH) Annual Meeting.

ASH is the world’s largest professional society of hematologists dedicated to furthering the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, including cancer. The annual meeting typically attracts more than 25,000 hematology professionals, including clinicians, researchers, medical students and patient advocates.

UNC Lineberger and UNC researchers presenting at the meeting include:


Friday, Dec. 8

Satellite Symposia

7-10 a.m. PT | Marriott Marquis San Diego, Pacific Ballroom Salons 21-22

Applying the Latest Evidence and NCCN Guideline Recommendations in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Presenter: Deborah Stephens, DO


ASH-a-Palooza Trainee Session

1:30-2 p.m., 2:40-3:10 p.m. and 4:35-5 p.m. | Petco Park, Sections 122 and 124

Blood Buddies: Adult Clinical Classical Hematology

Presenter: Alice Ma, MD


Saturday, Dec. 9

Education Program: How is the Management Paradigm Evolving for Hodgkin Lymphoma in 2023?

 4-5:15 p.m. PT | San Diego Convention Center, Ballroom 20CD

The Optimal Management of Relapsed and Refractory Hodgkin Lymphoma: Post-Brentuximab and Checkpoint Inhibitor Failure

Presenter: Natalie Grover, MD


Oral Abstract

 5-5:15 p.m. | San Diego Convention Center, Hall A

383 Risk of Transformation By Frontline Management in Follicular Lymphoma and Marginal Zone Lymphoma: A US Population-Based Analysis

Presenter: Jorge Florindez, MD


Poster Presentation

5:30-7:30 p.m. | San Diego Convention Center, Halls G-H

1692 Final Results of a Multicenter Pilot Study Evaluating Brentuximab Vedotin with Cyclophosphamide, Doxorubicin, Etoposide, and Prednisone (BV-CHEP) for the Treatment of Aggressive Adult T-Cell Leukemia/Lymphoma

Presenter: Christopher Dittus, DO, MPH


1113 Hypertonicity and/or Acidosis Induce Marked Rheological Changes Under Hypoxic Conditions in Sickle Trait Red Blood Cells

Presenter: Patrick Ellsworth, MD


1266 Association between Hereditary Angioedema and Venous Thromboembolism in a Large Population-Based Case-Control Study

Presenter: Steven Grover, PhD


2027 Outcomes Associated with Clone-Directed Therapies for Monoclonal Gammopathy of Renal Significance

Presenter: Daniel Peters, MD


2334 Treatment Outcome Priorities of Older Adults with Newly Diagnosed Blood Cancers Elicited with Best-Worst Scaling

Presenter: Daniel Richardson, MD, MSc, MA


Scientific Program

4-5:15 p.m. | San Diego Convention Center, Room 25

The Long Non-Coding Road, RNA and Signaling, and Regulation of Globin Gene Expression

Chair: Jane Little, MD


4-5:15 p.m. | San Diego Convention Center, Room 31

Mechanistic Role(s) of Neutrophil Extracellular Traps in Thrombosis

Chair: Rafal Pawlinski, PhD


Scientific Symposia

4-5:30 p.m. | San Diego Convention Center, Room 30

Disorders of Coagulation or Fibrinolysis: Clinical and Epidemiological: Beyond the Numbers: Non-Factor Factors in Bleeding Disorder Care

Co-moderator: Patrick Ellsworth, MD


Sunday, Dec. 10

Special Scientific Session on Race and Science: Bench to Bedside to the Community

 9:30-11 a.m. | San Diego Convention Center, Hall A

Basic Science Perspective: Alisa Wolberg, PhD


Oral Presentation

 4:30-6 p.m. | San Diego Convention Center, Room 33

564 Validation of Townes As Mice As a Model of Chronic Kidney Disease and Venous Thrombosis Associated with Sickle Cell Trait 

Presenter: Steven Grover, PhD


562 Pharmacologic Reduction of Platelet Count Attenuates Whole Blood Hypofibrinolysis in a Mouse Model of Sickle Cell Disease

Presenter: Anton Ilich, MD


Poster Presentation

6-8 p.m. | San Diego Convention Center | Halls G-H

2572 4D Intravital Imaging Studies Identify Platelets As the Predominant Cellular Procoagulant Surface in Hemostasis

Presenter: Abigail Ballard


3126 Rituximab Is Associated with an Increased Risk of Malaria Infection in a Malaria-Endemic Region

Presenter: Luke Eastburg, MD


Patients, Parents and Providers Perspectives Toward Treatment Options for Sickle Cell Disease

Presenter: Christopher Wanjiku, MD


3816 Real-World Treatment Patterns and Clinical Outcomes in Newly Diagnosed Acute Myeloid Leukemia with and without mIDH1 Treated with Intensive Chemotherapy from an International Real-World Database (REAL-IDH)

Presenter: Joshua Zeidner, MD


Medical Educators Symposium

7:30-9:30 a.m. | Hilton San Diego Bayfront

Breakout 5: Giving Good Feedback to Trainees

Speaker: Alice Ma, MD


Monday, Dec. 11

Poster Presentation

6-8 p.m. | San Diego Convention Center | Halls G-H

3894 High-Altitude Hypoxia Is  Common in Adults with Sickle Cell Disease

Presenter: Mofiyinfoluwa Obadina, MD


5107 Patterns of Emergency Department Utilization of Adolescents and Young Adults Living with Sickle Cell in North Carolina

Presenter: Samuel Wilson, MD


Special Symposium on the Basic Science in Hemostasis and Thrombosis

4:30-6 p.m. | San Diego Convention Center | Room 30

Co-Chair: Rafal Pawlinski, PhD


Novel Mechanisms for Targeting Fibrin(ogen) to Suppress Thrombosis

Presenter: Matthew Flick, PhD